Beth Hecht, Officer of Xeris Biopharma Holdings XERS, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $896.9K. The latest trade was on 06/01.

BH

BH

Beth Hecht

SEE REMARKS

Company

Xeris Biopharma Holdings XERS

First filing

23/02/01

Trades

32 trades

Buys / sales

0 / 10

12-month net buying

−$896.9K

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	06/01	06/02	16,667 sh	$6.06	$101,002.02	−1.4%
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	05/01	05/01	16,667 sh	$6.23	$103,835.41	−1.4%
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	04/01	04/03	16,667 sh	$5.99	$99,835.33	−1.4%
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	03/02	03/04	16,667 sh2 trades	$6.24avg.	$104,084.08	−1.3%
Xeris Biopharma HoldingsXERS	Open-market sale	02/02	02/02	16,667 sh	$7.45	$124,169.15	−1.3%
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	01/02	01/05	16,667 sh	$7.43	$123,835.81	−1.3%
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	25/12/01	25/12/02	16,667 sh	$7.01	$116,835.67	−1.2%
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	25/11/11	25/11/13	16,667 sh	$7.40	$123,335.8	−1.2%
Xeris Biopharma HoldingsXERS	Open-market sale	25/03/20	25/03/21	40,000 sh	$5.43	$217,200	−2.9%